These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33676240)

  • 1. Modeling microbe-host interaction in the pathogenesis of Crohn's disease.
    Ahmed M; Metwaly A; Haller D
    Int J Med Microbiol; 2021 Apr; 311(3):151489. PubMed ID: 33676240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.
    Schaubeck M; Clavel T; Calasan J; Lagkouvardos I; Haange SB; Jehmlich N; Basic M; Dupont A; Hornef M; von Bergen M; Bleich A; Haller D
    Gut; 2016 Feb; 65(2):225-37. PubMed ID: 25887379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut.
    Buttó LF; Haller D
    Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host and microbiota interactions are critical for development of murine Crohn's-like ileitis.
    Roulis M; Bongers G; Armaka M; Salviano T; He Z; Singh A; Seidler U; Becker C; Demengeot J; Furtado GC; Lira SA; Kollias G
    Mucosal Immunol; 2016 May; 9(3):787-97. PubMed ID: 26487367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.
    Buttó LF; Schaubeck M; Haller D
    Front Immunol; 2015; 6():555. PubMed ID: 26635787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's disease.
    Metwaly A; Jovic J; Waldschmitt N; Khaloian S; Heimes H; Häcker D; Ahmed M; Hammoudi N; Le Bourhis L; Mayorgas A; Siebert K; Basic M; Schwerd T; Allez M; Panes J; Salas A; Bleich A; Zeissig S; Schnupf P; Cominelli F; Haller D
    Microbiome; 2023 Mar; 11(1):66. PubMed ID: 37004103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paneth cell defects in Crohn's disease patients promote dysbiosis.
    Liu TC; Gurram B; Baldridge MT; Head R; Lam V; Luo C; Cao Y; Simpson P; Hayward M; Holtz ML; Bousounis P; Noe J; Lerner D; Cabrera J; Biank V; Stephens M; Huttenhower C; McGovern DP; Xavier RJ; Stappenbeck TS; Salzman NH
    JCI Insight; 2016 Jun; 1(8):e86907. PubMed ID: 27699268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice.
    Alula KM; Dowdell AS; LeBere B; Lee JS; Levens CL; Kuhn KA; Kaipparettu BA; Thompson WE; Blumberg RS; Colgan SP; Theiss AL
    Microbiome; 2023 Nov; 11(1):256. PubMed ID: 37978573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis.
    Sheikh IA; Bianchi-Smak J; Laubitz D; Schiro G; Midura-Kiela MT; Besselsen DG; Vedantam G; Jarmakiewicz S; Filip R; Ghishan FK; Gao N; Kiela PR
    Gut Microbes; 2024; 16(1):2333483. PubMed ID: 38532703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches.
    Núñez-Sánchez MA; Melgar S; O'Donoghue K; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Ruiz-Alcaraz AJ; Ramos-Molina B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model.
    He Q; Li X; Liu C; Su L; Xia Z; Li X; Li Y; Li L; Yan T; Feng Q; Xiao L
    Appl Microbiol Biotechnol; 2016 May; 100(10):4485-94. PubMed ID: 26795965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
    Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
    Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut dysbiosis and paediatric Crohn's disease.
    Brusaferro A; Cavalli E; Farinelli E; Cozzali R; Principi N; Esposito S
    J Infect; 2019 Jan; 78(1):1-7. PubMed ID: 30336176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TNF∆ARE Model of Crohn's Disease-like Ileitis.
    Metwaly A; Haller D
    Inflamm Bowel Dis; 2024 Jan; 30(1):132-145. PubMed ID: 37756666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook.
    Shen Z; Zhu C; Quan Y; Yuan W; Wu S; Yang Z; Luo W; Tan B; Wang X
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1804-1812. PubMed ID: 28677158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.